<DOC>
	<DOCNO>NCT01551836</DOCNO>
	<brief_summary>This single centre , open label , randomise , two-way crossover study healthy volunteer semi-fed condition . Two formulation paracetamol , test study establish time point therapeutic concentration paracetamol blood reach . Subjects attend screen visit check eligible study participation within 15 day check-in unit stay approximately 48 hour ( hr ) . They give single dose one preparation first day preparation next day . Regular blood sample take along assessment safety .</brief_summary>
	<brief_title>At What Time Therapeutic Plasma Concentrations Paracetamol Are Achieved Two Marketed Formulations</brief_title>
	<detailed_description />
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Males good general heatlh Body Mass Index 1928 kg/m2 Disease 1 . Current liver impairment , renal impairment , history active gastrointestinal ulcer , uncontrolled hypertension , haemophilia bleeding disorder . 2 . Current recurrent disease , within 12 month screen , could affect action , absorption disposition study formulation clinical laboratory assessment ( e.g . hepatic disorder , renal insufficiency , congestive heart failure ) . 3 . Current relevant previous history , within 12 month screen visit , serious , severe unstable physical psychiatric illness , medical disorder may require treatment make subject unlikely fully complete study , condition present undue risk study treatment procedure . Medications 1 . Current regular use screen prescription , herbal Over Counter ( OTC ) medication include paracetamol , aspirin , metaclopramide , domperidone , cholestyramine , angiotensin convert enzyme ( ACE ) inhibitor , acetazolamide , anticonvulsant , diuretic , methotrexate , nonsteroidal antiinflammatory drug ( NSAIDs ) oral hypoglycemics within past 48 hr monoamine oxidase inhibitor , tricyclic antidepressant , beta blocker anticoagulant warfarin heparin within past 2 week . 2 . Subjects take drug know induce inhibit hepatic drug metabolism 30 day prior screen visit ( examples inducer : barbiturate , theophylline ; inhibitor : cimetidine , erythromycin ) . 3 . Subjects use study drug contraindicate . Virology Screening Positive screen serum Hepatitis B surface antigen , Hepatitis C antibodies human immunodeficiency virus ( HIV ) . Drug Screen 1 . Positive urine screen drug abuse screen and/or Day1 . 2 . Positive alcohol breath test Day1 . Smoking 1 . Smoking five cigarette day . 2 . Prior ( within 7 day dose Day 1 ) current use nicotine containing product , cigarettes/pipes/cigars . Blood donation Has donate blood plasma blood product within 3 month screen visit . Subjects participation study would result donated 1500 ml blood within previous 12 month . Nutrition 1 . Is vegetarian sodium restrict diet . 2 . Has consume poppy seed contain food within 3 day prior screen visit admission Day 1 . 3 . Has consume food beverage contain grapefruit , Seville oranges marmalade within 24 hrs prior admission Day 1 . 4 . Has consume caffeine contain drink food ( e.g . tea , coffee , chocolate cola ) 24 hrs prior admission Day 1 . 5 . Has consume alcohol 36 hr prior admission Day 1 . Has undertake unusually strenuous physical activity 24 hr prior screen visit checkin Day 1 . Weight Weight 50 kg . Haemoglobin Subjects haemoglobin level 12.0 gram /decilitre ( dl ) .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>pharmacokinetics</keyword>
	<keyword>paracetamol</keyword>
</DOC>